Companies · Healthtech

Wellvana Health, LLC

NASHVILLE · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Wellvana Health, LLC — recommendation, valuation, rhythm, risks.
$161.2M
Total raised · real
5
Rounds
2.0×
Latest step-up
Top 4%
Sector rank · raised
Series C
Latest stage · inferred · Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Wellvana Health, LLC looks under-valued against its niche peers and is quiet on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.32× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era.
Quiet
  • Last raise 20 mo ago; this sector typically re-raises about every 14 months.
  • Slightly overdue versus sector cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Wellvana Health, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
4.2 yr record
Peak capital year was 2023 with $122.0M across 3 filings.
Market position
ahead of 97% of Healthtech peers
Capital scale is ahead of 97% of Healthtech peers; modeled value is above 83% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2023: $122.0M across 3 filings.
  • Largest single filing was $64.5M on 2023-02-24.
  • Filing rows sum to $171.2M, while canonical raised total is $161.2M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Wellvana Health, LLC is one of 2138 Healthtech companies tracked from NASHVILLE. By capital raised it ranks among the largest (ahead of 97% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2
Investors (latest)
2024-11-04
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries B · 2022-04-11 Raised $19M (real) Modeled valuation $267M (est)$19M$267MSeries B2022Series C · 2023-02-24 Raised $65M (real) Modeled valuation $795M (est)$65M$795MSeries C2023Series C · 2023-03-21 Raised $42M (real) Modeled valuation $508M (est)$42M$508MSeries C2023Series C · 2023-07-07 Raised $16M (real) Modeled valuation $173M (est)$16M$173MSeries C2023Series A · 2024-11-04 Raised $10M (real) Modeled valuation $44M (est)$10M$44MSeries A2024Series C · 2024-11-04 Raised $20M (real) Modeled valuation $154M (est)$20M$154MSeries C2024+$65M+$42M+$16M+$10M+$20MCumulative $171M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$19.1M · 2022
Series C$64.5M · 2023
Series C extension$42.0M · 2023
Series C extension$15.5M · 2023
Bridge · Series C-stage$10.0M · 2024smaller follow-on
Series C extension$20.0M · 2024

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 60%.

Modeled valuation trajectory
$154.4M
Base estimate est.
$72.7M
Conservative case
$223.7M
Upside case
$133.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series B · modeled $266.7M · 2022-04-112022Series C · modeled $794.9M · 2023-02-24Series C · modeled $507.7M · 2023-03-21Series C · modeled $172.7M · 2023-07-07Series A · modeled $43.9M · 2024-11-04Series C · modeled $154.4M · 2024-11-042024
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.32×/yr
Annual markup
1.51×/yr upside case
1.7 yr
Elapsed time used
1.7 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$62.8M/yr
Capital velocity
4.2 yr
On record since
2022
First round
6
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 36× above median
This company$161.2M
Sector median$4.5M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.4× of median
This company$20.0M
Sector median$46.5M
Modeled value — vs sector median (estimate, all stages) 4.6× above median
This company$154.4M
Sector median$33.8M

Raised more than 97% of sector peers (real $). Modeled value above 83% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #32 of 39.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Freedom Dental Funding, LLC · Series C Raised $100.0M · modeled $1.1B (est)Elevate Care International Topco LP · Series C Raised $98.4M · modeled $1.0B (est)Athelas Inc. · Series C Raised $54.4M · modeled $903.4M (est)Hazel Health, Inc. · Series C Raised $86.0M · modeled $817.6M (est)Health Gorilla, Inc. · Series C Raised $58.7M · modeled $816.3M (est)Employee Health Holdings, LP · Series C Raised $78.8M · modeled $779.7M (est)Magnolia Medical Technologies, Inc. · Series C Raised $94.2M · modeled $728.3M (est)Allied Health MSO Holdco, LLC · Series C Raised $62.8M · modeled $724.9M (est)Pearl Health, Inc. · Series C Raised $55.5M · modeled $721.8M (est)Veridian Healthcare Holdings LLC · Series C Raised $63.0M · modeled $692.5M (est)Accompany Health, Inc. · Series C Raised $56.3M · modeled $680.7M (est)Alleviant Medical, Inc. · Series C Raised $148.8M · modeled $677.4M (est)Wellvana Health, LLC (this company) Raised $161.2M · modeled $154.4M (est)Wellvana Health, LLC
CompanyStageRaised · realValue · estvs peer med.
Freedom Dental Funding, LLCSeries C$100.0M$1.1B2.33×
Elevate Care International Topco LPSeries C$98.4M$1.0B2.07×
Athelas Inc.Series C$54.4M$903.4M1.86×
Hazel Health, Inc.Series C$86.0M$817.6M1.68×
Health Gorilla, Inc.Series C$58.7M$816.3M1.68×
Employee Health Holdings, LPSeries C$78.8M$779.7M1.60×
Magnolia Medical Technologies, Inc.Series C$94.2M$728.3M1.50×
Allied Health MSO Holdco, LLCSeries C$62.8M$724.9M1.49×
Pearl Health, Inc.Series C$55.5M$721.8M1.48×
Veridian Healthcare Holdings LLCSeries C$63.0M$692.5M1.42×
Accompany Health, Inc.Series C$56.3M$680.7M1.40×
Alleviant Medical, Inc.Series C$148.8M$677.4M1.39×
Wellvana Health, LLC this companySeries C$161.2M$154.4M0.32×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$19.1M2022-04-11$106.2M$266.7M90%
Series C$64.5M2023-02-24$430.2M$794.9M90%
Series C$42.0M2023-03-21$280.0M$507.7M90%
Series C$15.5M2023-07-07$103.3M$172.7M90%
Series A$10.0M2024-11-04$45.5M$43.9M90%
Series C$20.0M2024-11-04$133.3M$154.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$19.1M2022-04-11
    • First recorded raise — entered as Series B.
    • 15 investors on this round.
  2. Series C$64.5M2023-02-24
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 3.4× larger than the prior — scaling up.
    • 13 investors on this round.
  3. Series C$42.0M2023-03-21
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  4. Series C$15.5M2023-07-07
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 2.7× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  5. Series A$10.0M2024-11-04
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  6. Series C$20.0M2024-11-04
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× larger than the prior — scaling up.
    • 2 investors on this round.
Intelligence
2025 ~Q2
Modeled next raise · ~6mo cadence
$40.0M
Modeled next size est.range $26.0M$64.0M
2.0×
Last step-up
$62.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Devin Carty9 other2022-04
JON PHILLIPS4 other2022-04
Rock Morphis4 other2023-02
Karey Witty1 other2023-07
Michael Platek1 other2022-04
Adam Haris Holland2023-02
Adam Holland2023-07
Cassie Smith2022-04
CHARLIE MARTIN2022-04
Darren Majors2022-04
IAN KYLE WAILES2024-11
KAREY HARIS WITTY2023-03
Kyle Wailes2022-04
Mark Montoney, MD2022-04
PHILLIP ROE2022-04
RAO HARIS NASEEM2023-02
Rao Naseem2023-07
Readus Smith2022-04
SCOTT HARIS LENZ2023-02
Scott Lenz2022-04
Sean Henson2022-04
Zachary Topper2022-04
Registry & provenance

Wellvana Health, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1925689
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Conversio Health, LLCHealthtechSeries B$39.0M$158.1Mnetwork2 shared operators · same sector
Axial Healthcare Holdings, L.P.HealthtechSeries C$45.0M$408.6Mnetwork1 shared operator · same sector · same stage
Conformal Medical, Inc.HealthtechSeries C$145.1M$200.5Msame sector · same stage
Eleanor Health Holdings, LlcHealthtechSeries C$138.0M$210.3Msame sector · same stage
Trice Medical, Inc.HealthtechSeries C$124.2M$115.8Msame sector · same stage
Lungpacer Medical, Inc.HealthtechSeries C$121.4M$69.8Msame sector · same stage
Hopscotch Health Holdings, LlcHealthtechSeries C$110.0M$101.9Msame sector · same stage
Convergent Dental, Inc.HealthtechSeries C$99.1M$119.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
WELL Health Technologies Corp.HealthtechSeed$92.8M90%
Wellvana San Antonio, LLCOther Health CareSeed$68.7M87%
Potomac Health Solutions, Inc.HealthtechPre-Seed$23.6M85%
Healthereum LLCHealthtechSeries B$495.7M85%
DPC Healthcare LLCHealthtechSeed$8.3M85%
Health Clinic Ventures LLCHealthtechPre-Seed$21.5M84%
Even Health LLCHealthtechSeed$25.3M84%
Diana Health, Inc.HealthtechSeries C$345.2M84%
Frequently asked
How much funding has Wellvana Health, LLC raised?
Wellvana Health, LLC has raised approximately $161.2M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Wellvana Health, LLC's estimated valuation?
Provath's modeled valuation for Wellvana Health, LLC is approximately $154.4M (modeled range $72.7M–$223.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Wellvana Health, LLC at?
Wellvana Health, LLC's latest modeled financing stage is Series C. Its most recent recorded round closed around Mon Nov 04.
What does Wellvana Health, LLC do and where is it based?
Wellvana Health, LLC operates in the Healthtech sector, based in NASHVILLE.
Explore related

See where Wellvana Health, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Wellvana Health, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.